Meningitis outbreak in Kent: The one thing every Norwegian student and parent needs to know
It's a news story that has travelled the globe in recent days: a serious outbreak of bacterial meningitis in Kent, south-east England. Two young people have lost their lives, and 13 are confirmed to be infected with the invasive bacteria. For those of us who keep an eye on health news, it naturally raises concern. Particularly because the dangerous strain B, known as MenB, has been identified as one of the main causes. But what exactly is happening, and why is this so serious? Let's delve into the matter, so you're left with the key points, without having to resort to heavy medical textbooks.
The nightclub that became a source of infection
The outbreak, which UK health authorities describe as serious, appears to have an epicentre: a nightclub in Canterbury. Authorities have traced the infection back to club visits on the 5th, 6th, and 7th of March, and are urging anyone who was there to contact the health service for antibiotics. The victims are young people, mainly aged 18–21, linked to a university and several secondary schools in the area. One of the deceased is an 18-year-old girl who attended a school in Faversham, another is a 21-year-old student at the University of Kent. It's a stark reminder that this illness can progress with frightening speed.
A "vaccination gap" explains the scale
Why is this affecting this particular group of young adults? Several experts point to what's known as a "vaccination gap." The meningococcal vaccine against the B strain (MenB) was first introduced into the UK childhood immunisation programme in 2015. This means that today's students, born before roughly 2015, were never offered this vaccine publicly. They are, quite simply, a generation unprotected against the most dangerous bacteria.
As one professor of infectious diseases points out, we're talking about a large cohort of unvaccinated students. And when young adults live closely together in student housing, at parties, and in nightclubs, the bacteria finds fertile ground. Many carry the meningococcal bacteria in their throats without becoming ill themselves, but can still spread it through close contact, coughing, or sharing drinks bottles.
How is an outbreak like this managed?
The response from UK authorities offers an interesting insight. It follows a standardised procedure to halt the spread of bacterial meningitis:
- Contact tracing and antibiotics: Close contacts of those infected are immediately offered antibiotics as a preventive dose. At the University of Kent, hundreds of students have queued up to receive them.
- Information and closures: The university has cancelled all in-person exams and assessments this week to minimise contact.
- Targeted vaccination: The health minister has confirmed they are now launching a targeted vaccination campaign for students living in halls of residence in the Kent area.
It's worth noting that while the outbreak is serious, health authorities stress it is localised to the Canterbury area, and they do not see it spreading to the rest of the country.
What does this mean for us in Norway?
For those of us living in Norway, this is a wake-up call, but no reason to panic. The Norwegian Institute of Public Health (FHI) is monitoring the situation closely. The most important thing we can learn from this is to know the symptoms. Meningitis can easily be mistaken for the flu or a hangover, which is especially dangerous for students who might not be tuned into their body's signals.
Pay particular attention to these signs:
- Sudden high fever
- Severe headache
- Neck stiffness (unable to bend the head forward towards the chest)
- Nausea and vomiting
- Sensitivity to light
- Characteristic rash (red or purplish spots that don't fade when you press a glass against them. This is a sign of blood poisoning.)
In Norway, we have good protection through the vaccination programme, but the MenB vaccine is still not part of the general programme for older adolescents and adults, unless they belong to risk groups (such as those without a functioning spleen). However, the FHI does recommend the vaccine for individuals, for example, students heading to countries with outbreaks, or young people going to "russefeiring" celebrations and festivals. So, if you have a 16–19-year-old at home planning to travel or take part in large gatherings, it might be a good idea to have a chat with your GP about the meningococcal vaccine.
The outbreak in Kent is a tragic reminder that this disease is still a threat, but with knowledge and the right vaccine, we can protect ourselves and those we care about.